Skip to main content
SpringerLink
Log in

ICER producing new evidence update on PCSK9 inhibitors

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Institute for Clinical and Economic Review. Institute for Clinical and Economic Review to Produce "New Evidence Update" Including Updated Value-based Price Benchmarks for PCSK9 Inhibitors to Treat High Cholesterol. Internet Document : 21 Mar 2017. Available from: URL: https://icer-review.org/announcements/pcsk9-new-evidence-update/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICER producing new evidence update on PCSK9 inhibitors. PharmacoEcon Outcomes News 774, 2 (2017). https://doi.org/10.1007/s40274-017-3826-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3826-x

Search

Navigation